Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 170   

Articles published

PFE 33.71 +0.93 (2.84%)
price chart
9 Figures That Sum Up Pfizer, Inc.'s First Quarter
After reporting rosy first-quarter financials and increasing its outlook for the year, Pfizer (NYSE:PFE) shares are trading higher.
Is Pfizer Inc. Finally Safe To Buy Again? (PFE)  Investorplace.com
Pfizer Inc. (PFE) To Report Q1 2016 Earnings; Revenue, Income Expected To Rise  International Business Times
Tuesday's Vital Data: Baidu Inc (ADR) (BIDU), Pfizer Inc. (PFE) and Valeant ...
U.S. stock futures are trading sharply lower heading into the open this morning, as weak Chinese economic data and an Australian interest-rate cut fueled fears of a weakening global economy.
Earnings Whispers: Pfizer Inc. (PFE), Halliburton Company (HAL) & CVS Health ...
Pfizer Inc. (NYSE:PFE), Halliburton Company (NYSE:HAL), and CVS Health Corp (NYSE:CVS) are about to report their first quarter financials in pre-market hours today.
Why Fidelity National Information Services (FIS), Pfizer Inc. (PFE) and Yelp ...
Why Fidelity National Information Services (FIS), Pfizer Inc. (PFE) and Renewed concerns about global economic growth sent investors scurrying into favored safe-haven assets, namely U.S.
Earnings Reaction History: Pfizer Inc, 40.0% Follow-Through Indicator, 1.4 ...
Pfizer Inc ( PFE ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.
Pfizer Inc. Q1 Profit Climbs 30%
(RTTNews.com) - Pfizer Inc. ( PFE ) released earnings for its first quarter that climbed from last year. The company said its bottom line came in at $4.16 billion, or $0.67 per share.
Pfizer Inc Vs. Merck & Co: Which Pharmaceutical Giant Should You Buy?
Two mega-cap pharma plays which have attracted my attention for some time are Pfizer (NYSE:PFE) and Merck & Co (NYSE:MRK).
Merck And Pfizer Earnings: Will They Beat Expectations Again?  Benzinga
BRIEF-Pfizer Inc reports Q1 adjusted earnings per share $0.67
May 3 Pfizer Inc. * Reports First Quarter 2016 results. * Q1 adjusted earnings per share $0.67. * Q1 earnings per share view $0.55 -- Thomson Reuters I/B/E/S.
Medivation Inc M&A Talk: Pfizer Inc Might Be a Contender
If Sanofi SA (ADR) (NYSE:SNY) does plan to aggressively pursue Medivation for takeover, it might face tough competition. Soon after the sought-after biotech company rejected Sanofi's $9.3 billion takeover bid on Friday, Bloomberg reported, citing ...
Exclusive: Pfizer approaches Medivation about potential takeover - sources  Channel News Asia
Notable Analyst's Ranking Preview: Pfizer, Inc. (NYSE:PFE) , StemCells, Inc ...
Pfizer, Inc. (NYSE:PFE) accumulated +0.28%, closing at $32.80 after floating between $32.50 and $33.00. The company has market capitalization of $202.47B.